Jacob Soumerai, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Belantamab Mafodotin In Plasmablastic Lymphoma & ALK+ Large B-Cell Lymphoma (NCT04676360) | Jacob Soumerai, MD | 2021-07-01 |
Track Jacob Soumerai, MD automatically
Every clearance here is in the API, with alerts when new ones post.